1. Home
  2. LGND
  3. LGND News

Latest Ligand Pharmaceuticals Incorporated (LGND) News on March 31, 2025

LGND: First Steps into Cell & Gene Therapy

Zacks Small Cap Research

a month ago

LGND: First Steps into Cell & Gene Therapy

Associated Press Finance

a month ago

Ligand: Q4 Earnings Snapshot

Argus Research

3 months ago

LGND: Lowering target price to $114.00

LGND: 2025 View Calls for 17% Topline Growth

Zacks Small Cap Research

3 months ago

LGND: 2025 View Calls for 17% Topline Growth

LGND: 3Q Sales Surprise to the Upside

Zacks Small Cap Research

5 months ago

LGND: 3Q Sales Surprise to the Upside

Associated Press Finance

5 months ago

Ligand: Q3 Earnings Snapshot

Associated Press Finance

8 months ago

Ligand: Q2 Earnings Snapshot

Share on Social Networks: